Answers are grounded in this paper and cite their sources.
Systemic medications may gain access to the cornea and conjunctiva through the tear film, aqueous humor or limbal and conjunctival vasculature. Clofazimine is a lipophilic iminophenazine antibiotic used in the treatment of leprosy. Corneal changes may result in reduced visual acuity, photophobia, and ocular irritation, though these symptoms typically resolve following drug cessation. This report discusses clofazimine induced pigmentation of conjunctiva and cornea in a patient with borderline lepromatous Hansen’s disease who had been on clofazimine therapy.
No takes yet. Share an insight, caveat, or question.
John et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: